在多发性骨髓瘤的临床前模型中,轻微植物性大麻素的抗癌作用
Cristina Aguzzi1,2, Laura Zeppa1,2, Maria Beatrice Morelli1,2
1School of Pharmacy, University of Camerino, Camerino, MC, Italy.
BioFactors (Oxford, England)
|May 18, 2024
概括
像CBG,CBC,CBN和CBDV这样的轻微植物性大麻素对多发性骨髓瘤 (MM) 显示出抗癌作用. 这些化合物抑制了MM细胞的生长,减少了侵袭,减少了骨的再吸收,CBN在体内证明有效.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 是一种具有显著骨并发症的血细胞恶性瘤.
- 目前的MM治疗缺乏治愈潜力,导致耐药性疾病.
- 大麻素显示出抗癌性质,但植物性大麻素对MM的轻微影响未得到充分研究.
研究的目的:
- 研究CBG,CBC,CBN和CBDV对MM细胞的细胞毒性和抗侵入性作用.
- 评估这些植物性大麻素对MM诱导的骨再吸收的影响.
- 在体内MM异种移植模型中评估CBN的疗效.
主要方法:
- 在实验室中评估MM细胞系中植物大麻素细胞毒性和抗入侵活性.
- 对植物大麻素对骨质细胞和骨再吸收的影响的评估.
- 在体内研究,使用多发性骨髓瘤异种移植小鼠模型与CBN治疗.
主要成果:
- CBG,CBC,CBN和CBDV表现出细胞毒性作用,抑制MM细胞的增殖并诱导死细胞死亡.
- 植物性大麻素显著降低了对骨质细胞的MM细胞入侵,并在体外抑制了骨的再吸收.
- 在体内MM异种移植模型中,CBN治疗导致瘤质量减少.
结论:
- 较小的植物性大麻素 (CBG,CBC,CBN,CBDV) 对多发性骨髓瘤表现出有希望的抗癌活性.
- 这些化合物具有减轻MM相关骨病的潜力.
- 根据CBN的说法,该药物作为多发性骨髓瘤的治疗剂需要进一步调查.
相关概念视频
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
229
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
229
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


